FELICIONI, LARA BARBARA

FELICIONI, LARA BARBARA  

DIPARTIMENTO DI MEDICINA E SCIENZE DELL'INVECCHIAMENTO  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.06 secondi).
Titolo Data di pubblicazione Autore(i) File
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 2012 Schirosi, L; Nannini, N; Nicoli, D; Cavazza, A; Valli, R; Buti, S; Garagnani, L; Sartori, G; Calabrese, F; Marchetti, Antonio; Buttitta, Fiamma; Felicioni, LARA BARBARA; Migaldi, M; Rea, F; Di Chiara, F; Mengoli, Mc; Rossi, G.
AKT1(E17K) in human solid tumours 2008 Bleeker, Fe; Felicioni, LARA BARBARA; Buttitta, Fiamma; Lamba, S; Cardone, L; Rodolfo, M; Scarpa, A; Leenstra, S; Frattini, M; Barbareschi, M; Grammastro, Md; Sciarrotta, Mariagrazia; Zanon, C; Marchetti, Antonio; Bardelli, A.
Assessing EGFR mutations. 2006 Marchetti, Antonio; Felicioni, LARA BARBARA; Buttitta, Fiamma
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 2014 Marchetti, Antonio; Del Grammastro, Maela; Felicioni, Lara; Malatesta, Sara; Filice, Giampaolo; Centi, Irene; De Pas, Tommaso; Santoro, Armando; Chella, Antonio; Brandes, Alba Ariela; Venturino, Paola; Cuccurullo, Franco; Crinò, Lucio; Buttitta, Fiamma
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 2011 Marchetti, Antonio; Felicioni, LARA BARBARA; Malatesta, Sara; Sciarrotta, Mariagrazia; Guetti, Luigi; Chella, A; Viola, Patrizia; Pullara, C; Mucilli, Felice; Buttitta, Fiamma
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 2009 Marchetti, Antonio; Milella, M; Felicioni, LARA BARBARA; Cappuzzo, F; Irtelli, L; DEL GRAMMASTRO, Maela; Sciarrotta, Mariagrazia; Malatesta, Sara; Nuzzo, C; Finocchiaro, G; Perrucci, B; Carlone, D; Gelibter, Aj; Ceribelli, A; Mezzetti, Andrea; Iacobelli, Stefano; Cognetti, F; Buttitta, Fiamma
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 2012 Marchetti, Antonio; DEL GRAMMASTRO, Maela; Filice, Giampaolo; Felicioni, LARA BARBARA; Giulio, Rossi; Paolo, Graziano; Giuliana, Sartori; Alvaro, Leone; Malatesta, Sara; Michele, Iacono; Luigi, Guetti; Patrizia, Viola; Mucilli, Felice; Cuccurullo, Franco; Buttitta, Fiamma
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 2005 Marchetti, Antonio; Barassi, Fabio; Felicioni, LARA BARBARA; Martella, Carla; Salvatore, S; Mezzetti, Andrea; Cuccurullo, Franco; Buttitta, Fiamma; Chella, A; Camplese, Pierpaolo; Iarussi, T; Mucilli, Felice; Sacco, Rocco
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 2007 Barbareschi, M; Buttitta, Fiamma; Felicioni, LARA BARBARA; Cotrupi, S; Barassi, Fabio; DEL GRAMMASTRO, Maela; Ferro, A; Dalla Palma, P; Galligioni, E; Marchetti, Antonio
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 2012 Milella, M; Nuzzo, C; Bria, E; Sperduti, I; Visca, P; Buttitta, Fiamma; Antoniani, B; Merola, R; Gelibter, A; Cuppone, F; D'Alicandro, V; Ceribelli, A; Rinaldi, M; Cianciulli, A; Felicioni, LARA BARBARA; Malatesta, Sara; Marchetti, Antonio; Mottolese, M; Cognetti, F.
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 2003 Buttitta, Fiamma; Pellegrini, C.; Marchetti, Antonio; Gadducci, A.; Cosio, S.; Felicioni, LARA BARBARA; Barassi, Fabio; Salvatore, S.; Martella, Carla; Coggi, G.; Bosari, S.
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 2005 Giglio, S; Mancini, F; Gentiletti, F; Sparaco, G; Felicioni, LARA BARBARA; Barassi, Fabio; Martella, Carla; Prodosmo, A; Iacovelli, S; Buttitta, Fiamma; Farsetti, A; Soddu, S; Marchetti, Antonio; Sacchi, A; Pontecorvi, A; Moretti, F.
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 2009 Bleeker, Fe; Lamba, S; Leenstra, S; Troost, D; Hulsebos, T; Vandertop, Wp; Frattini, M; Molinari, F; Knowles, M; Cerrato, A; Rodolfo, M; Scarpa, A; Felicioni, LARA BARBARA; Buttitta, Fiamma; Malatesta, Sara; Marchetti, Antonio; Bardelli, A.
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 2011 Molinari, F; Felicioni, LARA BARBARA; Buscarino, M; De Dosso, S; Buttitta, Fiamma; Malatesta, Sara; Movilia, A; Luoni, M; Boldorini, R; Alabiso, O; Girlando, S; Soini, B; Spitale, A; Di Nicolantonio, F; Saletti, P; Crippa, S; Mazzucchelli, L; Marchetti, Antonio; Bardelli, A; Frattini, M.
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 2009 Cappuzzo, F; Marchetti, Antonio; Skokan, M; Rossi, E; Gajapathy, S; Felicioni, LARA BARBARA; DEL GRAMMASTRO, Maela; Sciarrotta, Mariagrazia; Buttitta, Fiamma; Incarbone, M; Toschi, L; Finocchiaro, G; Destro, A; Terracciano, L; Roncalli, M; Alloisio, M; Santoro, A; Varella Garcia, M.
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 2006 Bon, G; Folgiero, V; Bossi, G; Felicioni, LARA BARBARA; Marchetti, Antonio; Sacchi, A; Falcioni, R.
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 2009 Mancini, F; Di Conza, G; Pellegrino, M; Rinaldo, C; Prodosmo, A; Giglio, S; D'Agnano, I; Florenzano, F; Felicioni, LARA BARBARA; Buttitta, Fiamma; Marchetti, Antonio; Sacchi, A; Pontecorvi, A; Soddu, S; Moretti, F.
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 2009 Balakrishnan, A; Penachioni, Jy; Lamba, S; Bleeker, Fe; Zanon, C; Rodolfo, M; Vallacchi, V; Scarpa, A; Felicioni, LARA BARBARA; Buck, M; Marchetti, Antonio; Comoglio, Pm; Bardelli, A; Tamagnone, L.
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 2001 Marchetti, Antonio; Buttitta, Fiamma; Bertacca, G; Zavaglia, K; Bevilacqua, G; Angelucci, D; Viacava, P; Naccarato, A; Bonadio, A; Barassi, Fabio; Felicioni, LARA BARBARA; Salvatore, S; Mucilli, Felice
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 2006 Buttitta, Fiamma; Barassi, Fabio; Fresu, G; Felicioni, LARA BARBARA; Chella, A; Paolizzi, D; Lattanzio, Giuseppe; Salvatore, S; Camplese, Pierpaolo; Rosini, Sandra; Iarussi, T; Mucilli, Felice; Sacco, Rocco; Mezzetti, Andrea; Marchetti, Antonio